![The F-35’s future: Can the fifth-gen fighter withstand political, technological headwinds? [Video]](https://breakingdefense.com/wp-content/uploads/sites/3/2024/04/240401_f35_clouds_8270083-scaled-e1711999276822.jpg?#)
Human medicines European public assessment report (EPAR): HBVaxPro, hepatitis B vaccine (recombinant DNA), Date of authorisation: 27/04/2001, Revision: 34, Status: Authorised
Human medicines European public assessment report (EPAR): HBVaxPro, hepatitis B vaccine (recombinant DNA), Date of authorisation: 27/04/2001, Revision: 34, Status: Authorised
Human medicines European public assessment report (EPAR): HBVaxPro, hepatitis B vaccine (recombinant DNA), Date of authorisation: 27/04/2001, Revision: 34, Status: Authorised
